In comparison with other industries, the use of AI is modest in life sciences. However, even within life sciences, adoption of AI in regulated environments, such as in the R&D value chain, is further behind. Sivakumar Thiagarajan
Sivakumar Thiagarajan
Advertisement
Sivakumar Thiagarajan is Vice President â R&D â¨(Clinical, Regulatory, Safety) at Indegene.
Articles by Sivakumar Thiagarajan
Advertisement
Latest Updated Articles
- AI in the R&D Value Chain
Published: October 21st 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
